BioCentury | Aug 1, 2020
Management Tracks

Nabel leaves Moderna’s board to avoid conflict-of-interest concerns; plus changes at Genespire, La Jolla, Editas and more

...and CEO of La Jolla Pharmaceutical Co. (NASDAQ:LJPC) as the company completes its acquisition of Tetraphase...
BioCentury | Jul 30, 2020
Finance

July 28 Quick Takes: Venture round reveals for Omega, Praxis, HaiHe; plus trio of NASDAQ IPO filings, Atsena’s debut, La Jolla-Tetraphase

...La Jolla completes Tetraphase takeout La Jolla Pharmaceutical Company (NASDAQ:LJPC) has completed its acquisition of Tetraphase...
...million tied to U.S. sales of Xerava eravacycline, an antibiotic for complicated intra-abdominal infections (see “Tetraphase...
BioCentury | Jun 25, 2020
Deals

June 24 Quick Takes: CSL pays $450M for uniQure’s hemophilia gene therapy; plus Merck-Yumanity, Editas, Compass-Olivia, Century-Empirica, Tetraphase-La Jolla

...Cancer” ). Tetraphase moves on to third dance partner In its second about-face this month, Tetraphase...
...million in milestones. Tetraphase will pay Melinta a $1.2 million termination fee. Elizabeth S. Eaton, Staff Writer Tetraphase...
BioCentury | Jun 6, 2020
Product Development

June 5 Quick Takes: Merck, Tetraphase-Melinta, Apeiron, Neurasic, Jounce, Genmab-J&J

...is already approved for complicated intra-abdominal and urinary tract infections. Tetraphase forgoes AcelRx for Melinta Tetraphase...
...enzyme 2 LILRB2 (LIR2) - Leukocyte immunoglobulin-like receptor subfamily B member 2 BioCentury Staff HCQ, hydroxychloroquine Recarbrio, Relebactam/imipenem/cilastatin FDC Tetraphase...
BioCentury | Jun 4, 2020
Finance

Everest to fund late-stage trials with $310M mountain of fresh cash

...slice of global economics. Everest has already received approval in Singapore of one drug, Xerava eravacycline...
...is in Phase III development in China. Everest’s partner Tetraphase Pharmaceuticals Inc. (NASDAQ:TTPH) has gained eravacycline’s...
BioCentury | May 8, 2020
Product Development

May 7 Quick Takes: Gaboxadol meets in Phase II for Fragile X; plus Innovent, Lilly, Tetraphase and more

...metastatic squamous non-small cell lung cancer. La Jolla counters AcelRx’s bid for Tetraphase Antibiotic company Tetraphase...
...million in contingent value rights. In March, AcelRx Pharmaceuticals Inc. (NASDAQ:ACRX) announced plans to acquire Tetraphase...
...2 BioCentury Staff Nerlynx (Brand), PB272 (Compound #), HKI-272 (Compound #), Oral neratinib (Generic) Puma Biotechnology Inc. Canbridge Pharmaceuticals Inc. Tetraphase...
BioCentury | Apr 18, 2020
Regulation

Trio of approvals includes Seattle Genetics’ breast cancer therapy

...approved Xerava eravacycline to treat complicated intra-abdominal infections in adults. Everest has exclusive rights from Tetraphase...
...factor receptor 2 FGFR - Fibroblast growth factor receptor Elizabeth S. Eaton, Staff Writer tucatinib pemigatinib (INCB054828, INCB54828) Xerava, eravacycline...
BioCentury | Mar 17, 2020
Product Development

March 16 Quick Takes: FDA raises efficacy questions for DBV allergy therapy; plus Novo, Provention, UCB, Pfizer-EMD Serono, Zai, AcelRx-Tetraphase, Medivir-Tan

...GlaxoSmithKline plc (LSE:GSK; NYSE:GSK). AcelRx buying antibiotic company Tetraphase AcelRx Pharmaceuticals Inc. (NASDAQ:ACRX) will acquire Tetraphase...
...Inc. (NASDAQ:TTPH) for about $14.4 million in a stock for stock deal. For each share, Tetraphase...
...worth an aggregate of up to $12.5 million in sales milestones for the antibiotic Xerava eravacycline...
BioCentury | Dec 11, 2019
Clinical News

Iterum antibiotic fails in Phase III for intra-abdominal infections, further driving down shares

...bankruptcy in April despite the June 2018 approval Zemdri plazomicin. Paratek Pharmaceuticals Inc. (NASDAQ:PRTK) and Tetraphase...
BioCentury | Aug 16, 2019
Company News

Ahead of FDA decisions on one antibiotic, Nabriva plans resubmission of another

...plazomicin. Two other companies that received antibiotic approvals last year, Paratek Pharmaceuticals Inc. (NASDAQ:PRTK) and Tetraphase...
Items per page:
1 - 10 of 141